Andrzej Joachimiak

Andrzej Joachimiak

Auto-generated profile, based on publicly available information

Andrzej Joachimiak

University of Chicago

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2006 in Science
Verified
Journal Article
Closed access
PDF file
JMJoseph D. Mougous
Joseph D. Mougous
MCMarianne E. Cuff
Marianne E. Cuff
SRStefan Raunser
Stefan Raunser
ASAimee Shen
Aimee Shen
MZMin Zhou
Min Zhou
JMJohn J. Mekalanos
John J. Mekalanos
Bacterial pathogens frequently use protein secretion to mediate interactions with their hosts. Here we found that a virulence locus (HSI-I) of Pseudomonas aeruginosa encodes a protein secretion apparatus. The apparatus assembled in discrete subcellular locations and exported Hcp1, a hexameric protein that forms rings with a 40 angstrom internal diameter. Regulatory patterns of HSI-I suggested that the apparatus functions during chronic infections. We detected Hcp1 in pulmonary secretions of cystic fibrosis (CF) patients and Hcp1-specific antibodies in their sera. Thus, HSI-I likely contributes to the pathogenesis of P. aeruginosa in CF patients. HSI-I–related loci are widely distributed among bacterial pathogens and may play a general role in mediating host interactions.

2 February 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
JOJerzy Osipiuk
Jerzy Osipiuk
SASaara-Anne Azizi
Saara-Anne Azizi
SDSteve Dvorkin
Steve Dvorkin
MEMichael Endres
Michael Endres
RJRobert Jedrzejczak
Robert Jedrzejczak
AJAndrzej Joachimiak
Andrzej Joachimiak
The pandemic caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to expand. Papain-like protease (PLpro) is one of two SARS-CoV-2 proteases potentially targetable with antivirals. PLpro is an attractive target because it plays an essential role in cleavage and maturation of viral polyproteins, assembly of the replicase-transcriptase complex, and disruption of host responses. We report a substantive body of structural, biochemical, and virus replication studies that identify several inhibitors of the SARS-CoV-2 enzyme. We determined the high resolution structure of wild-type PLpro, the active site C111S mutant, and their complexes with inhibitors. This collection of structures details inhibitors recognition and interactions providing fundamental molecular and mechanistic insight into PLpro. All compounds inhibit the peptidase activity of PLpro in vitro, some block SARS-CoV-2 replication in cell culture assays. These findings will accelerate structure-based drug design efforts targeting PLpro to identify high-affinity inhibitors of clinical value.

24 June 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
DKDaniel W. Kneller
Daniel W. Kneller
GPGwyndalyn Phillips
Gwyndalyn Phillips
HOHugh M. O’nEill
Hugh M. O’nEill
RJRobert Jedrzejczak
Robert Jedrzejczak
LSLucy Stols
Lucy Stols
AKAndrey Kovalevsky
Andrey Kovalevsky
The COVID-19 disease caused by the SARS-CoV-2 coronavirus has become a pandemic health crisis. An attractive target for antiviral inhibitors is the main protease 3CL Mpro due to its essential role in processing the polyproteins translated from viral RNA. Here we report the room temperature X-ray structure of unliganded SARS-CoV-2 3CL Mpro, revealing the ligand-free structure of the active site and the conformation of the catalytic site cavity at near-physiological temperature. Comparison with previously reported low-temperature ligand-free and inhibitor-bound structures suggest that the room temperature structure may provide more relevant information at physiological temperatures for aiding in molecular docking studies.

17 April 2020 in Protein Science
Verified
Journal Article
Open access
PDF file
YKYoungchang Kim
Youngchang Kim
RJRobert Jedrzejczak
Robert Jedrzejczak
NMNatalia I. Maltseva
Natalia I. Maltseva
MWMateusz Wilamowski
Mateusz Wilamowski
MEMichael Endres
Michael Endres
AJAndrzej Joachimiak
Andrzej Joachimiak
Severe Acute Respiratory Syndrome coronavirus 2 (SARS‐CoV‐2) is rapidly spreading around the world. There is no existing vaccine or proven drug to prevent infections and stop virus proliferation. Although this virus is similar to human and animal SARS‐CoVs and Middle East Respiratory Syndrome coronavirus (MERS‐CoVs), the detailed information about SARS‐CoV‐2 proteins structures and functions is urgently needed to rapidly develop effective vaccines, antibodies, and antivirals. We applied high‐throughput protein production and structure determination pipeline at the Center for Structural Genomics of Infectious Diseases to produce SARS‐CoV‐2 proteins and structures. Here we report two high‐resolution crystal structures of endoribonuclease Nsp15/NendoU. We compare these structures with previously reported homologs from SARS and MERS coronaviruses.

2 April 2004 in Proteins: Structure, Function, and Bioinformatics
Verified
Journal Article
Closed access
PDF file
EHE.I. Howard
E.I. Howard
RSR. Sanishvili
R. Sanishvili
RCR.E. Cachau
R.E. Cachau
AMA. Mitschler
A. Mitschler
BCB. Chevrier
B. Chevrier
APA. Podjarny
A. Podjarny

9 July 2008 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
ANAndy Ka‐Leung Ng
Andy Ka‐Leung Ng
HZHongmin Zhang
Hongmin Zhang
KTKemin Tan
Kemin Tan
ZLZongli Li
Zongli Li
JLJin‐Huan Liu
Jin‐Huan Liu
P.C. ShawP.C. Shaw
P.C. Shaw
The threat of a pandemic outbreak of influenza virus A H5N1 has become a major concern worldwide. The nucleoprotein (NP) of the virus binds the RNA genome and acts as a key adaptor between the virus and the host cell. It, therefore, plays an important structural and functional role and represents an attractive drug target. Here, we report the 3.3‐Å crystal structure of H5N1 NP, which is composed of a head domain, a body domain, and a tail loop. Our structure resolves the important linker segments (residues 397–401, 429–437) that connect the tail loop with the remainder of the molecule and a flexible, basic loop (residues 73–91) located in an arginine‐rich groove surrounding Arg150. Using surface plasmon resonance, we found the basic loop and arginine‐rich groove, but mostly a protruding element containing Arg174 and Arg175, to be important in RNA binding by NP. We also used our crystal structure to build a ring‐shaped assembly of nine NP subunits to model the miniribonucleo‐protein particle previously visualized by electron microscopy. Our study of H5N1 NP provides insight into the oligomerization interface and the RNA‐binding groove, which are attractive drug targets, and it identifies the epitopes that might be used for universal vaccine development.—Ng, A. K.‐L., Zhang, H., Tan, K., Li, Z., Liu, J.‐h., Chan, P. K.‐S., Li, S.‐M., Chan, W.‐Y., Au, S. W.‐N., Joachimiak, A., Walz, T., Wang, J.‐H., Shaw, P.‐C. Structure of the influenza virus A H5N1 nucleoprotein: implications for RNA binding, oligomerization, and vaccine design. FASEB J. 22, 3638–3647 (2008)